SomniGroup (SGI) CEO discloses stock awards, vesting and share holdings
Rhea-AI Filing Summary
SomniGroup International Inc. president and CEO reports multiple equity transactions on January 2, 2026. The Form 4 shows several blocks of common stock acquired at $0 per share under vested restricted stock units and performance restricted stock units, followed by share disposals at $88.74 per share to cover tax withholding. After these transactions, the reporting person directly beneficially owns 295,869 shares of SomniGroup common stock and indirectly owns 22,400 shares through a family limited liability company.
In the derivative table, previously granted RSUs and performance RSUs convert into common stock on a one-for-one basis as they vest under awards originally granted between 2022 and 2025. The filing also discloses a new grant on January 2, 2026 of 14,086 restricted stock units, scheduled to vest in four annual installments on January 4 of 2027, 2028, 2029 and 2030.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 4,019 | $0.00 | -- |
| Exercise | Restricted Stock Units | 5,547 | $0.00 | -- |
| Exercise | Restricted Stock Units | 4,043 | $0.00 | -- |
| Exercise | Restricted Stock Units | 3,476 | $0.00 | -- |
| Exercise | Performance Restricted Stock Units | 4,588 | $0.00 | -- |
| Exercise | Performance Restricted Stock Units | 14,909 | $0.00 | -- |
| Exercise | Performance Restricted Stock Units | 6,508 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 14,086 | $0.00 | -- |
| Exercise | Common Stock | 4,019 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,833 | $88.74 | $163K |
| Exercise | Common Stock | 5,547 | $0.00 | -- |
| Tax Withholding | Common Stock | 2,530 | $88.74 | $225K |
| Exercise | Common Stock | 4,043 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,844 | $88.74 | $164K |
| Exercise | Common Stock | 3,476 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,586 | $88.74 | $141K |
| Exercise | Common Stock | 4,588 | $0.00 | -- |
| Tax Withholding | Common Stock | 2,093 | $88.74 | $186K |
| Exercise | Common Stock | 14,909 | $0.00 | -- |
| Tax Withholding | Common Stock | 6,908 | $88.74 | $613K |
| Exercise | Common Stock | 6,508 | $0.00 | -- |
| Tax Withholding | Common Stock | 2,968 | $88.74 | $263K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Performance restricted stock units and restricted stock units convert into common stock on a one-for-one basis. On January 4, 2022, the reporting person was granted 16,076 restricted stock units, vesting in four annual installments beginning on the first anniversary of the grant date. On January 4, 2023, the reporting person was granted 22,187 restricted stock units, vesting in four annual installments beginning on the first anniversary of the grant date. On January 4, 2024, the reporting person was granted 16,173 restricted stock units, vesting in four annual installments beginning on the first anniversary of the grant date. On January 3, 2025, the reporting person was granted 13,904 restricted stock units, vesting in four annual installments on January 4, 2026, 2027, 2028 and 2029. On January 4, 2022, the reporting person was granted a target number of performance shares, with the payout from 0 to 300% of target based on the Company's adjusted EBITDA, Relative TSR Percentile and qualitative ESG performance. The Human Resources/Capital and Talent Committee of the Board of Directors determined the payout for each metric on February 17, 2023 resulting in the reported number of performance shares received. The PRSUs vest in approximately three equal installments on January 4, 2024, 2025 and 2026. On January 4, 2023, the reporting person was granted a target number of performance shares, with the payout from 0 to 300% of target based on the Company's adjusted EBITDA, Relative TSR Percentile and qualitative ESG performance. The Human Resources/Capital and Talent Committee of the Board of Directors determined the payout for each metric on February 16, 2024 resulting in the reported number of performance shares received. The PRSUs vest in approximately three equal installments on January 4, 2025, 2026 and 2027. On January 4, 2024, the reporting person was granted a target number of performance shares, with the payout from 0 to 300% of target based on the Company's adjusted EPS, adjusted EBITDA and qualitative Strategic Initiatives performance. The Human Resources/Capital and Talent Committee of the Board of Directors determined the payout for each metric on February 28, 2025 resulting in the reported number of performance shares received. The PRSUs vest in approximately three equal installments on January 4, 2026, 2027 and 2028. On January 2, 2026, the reporting person was granted 14,086 restricted stock units, vesting in four annual installments on January 4, 2027, 2028, 2029 and 2030.
FAQ
What insider activity did SomniGroup International Inc. (SGI) report on this Form 4?
The Form 4 reports that the president and CEO of SomniGroup International Inc. completed multiple equity transactions on January 2, 2026, including stock received from vesting restricted stock units and performance restricted stock units, related share withholding transactions, and a new grant of restricted stock units.
What new equity award did the SomniGroup (SGI) president receive on January 2, 2026?
On January 2, 2026, the reporting person was granted 14,086 restricted stock units, which are scheduled to vest in four annual installments on January 4 of 2027, 2028, 2029 and 2030.
How do SomniGroup (SGI) restricted stock units and performance restricted stock units convert into common stock?
The explanation states that performance restricted stock units and restricted stock units convert into common stock on a one-for-one basis, meaning each unit represents one share of SomniGroup common stock when it vests.
What prior SomniGroup (SGI) equity grants are referenced in this Form 4?
The filing references RSU and performance share grants made on January 4, 2022, January 4, 2023, January 4, 2024, and January 3, 2025, with vesting schedules over multiple years and payouts based on metrics such as adjusted EBITDA, Relative TSR Percentile, adjusted EPS, and qualitative ESG or Strategic Initiatives performance.